Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Mambuque E, Del Amo-de Palacios A, Huete SG, Marsh CC, Theron G, García-Basteiro AL, Serrano-Villar S.

    Beyond bacilli: integrating the microbiome into the TB research agenda.

    Gut Microbes . 18(1): 2638004-2638004.

    [doi:10.1080/19490976.2026.2638004]

  • Moreno Guillén S, Redondo Margüello E, Rodríguez García J, Aceituno S, Prades M, Yang J, López Rodríguez Á, Molina C, López-Ibáñez de Aldecoa A.

    Estimating the public health and economic impact of increased COVID-19 annual vaccination coverage in the 60 years and older population in Spain.

    JOURNAL OF MEDICAL ECONOMICS . 29(1): 940-956.

    [doi:10.1080/13696998.2026.2643130]

  • Berenguer J, Ryan P, Ramos-Ruperto L, Martín-Carbonero L, Pérez-Latorre L, Santos IL, Pinto A, Vivancos MJ, Orviz E, Álvarez B, Sanz J, Ruiz-Seco P, Torres R, De Miguel M, Esteban H, Jarrín I, Resino S, Bellón JM, González-García J.

    Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV.

    AIDS . 40(12): 1807-1816.

    [doi:10.1097/QAD.0000000000004614]

  • Calderón-Parra J, Diego-Yagüe I, Muñoz P, Fariñas-Alvarez MC, Ruiz-Alonso N, Alvarez-Uría A, Martínez-Sellés M, Rodríguez-Esteban MA, Ojeda-Burgos G, Goikoetxea-Agirre AJ, De Alarcón A, Miró JM, Loeches-Yagüe B, Martínez-Ramos A.

    Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort.

    CLINICAL MICROBIOLOGY AND INFECTION . 32(11): 1846-1855.

    [doi:10.1016/j.cmi.2026.04.027]

  • Brañas F, Galindo MJ, Torralba M, Antela A, Montes ML, Bustinduy MJ, Cabello N, Cabello A, Ramírez M, Ryan P, Bustingorri I, Machuca I, Sánchez-Conde M.

    Quality of life among older adults with HIV after switching to bictegravir-based three-drug or dolutegravir-based two-drug regimens.

    HIV MEDICINE . 27(11): 1896-1902.

    [doi:10.1111/hiv.70310]

  • Fernández-Ruiz M, Gutiérrez-Gutiérrez B, Escrihuela-Vidal F, Muñoz P, Carratalà J, Fortún J, Salavert M, Torre-Cisneros J, Aguado JM.

    How can we optimize the diagnostic and therapeutic approach to Staphylococcus aureus bacteremia? Expert opinion-based recommendations.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 44(9): 503253-503253.

    [doi:10.1016/j.eimce.2026.503253]

  • Berenguer J, Ryan P, Lutz T, Martín-Carbonero L, Pérez-Latorre L, Vivancos MJ, Navarro J, Navarro-Soler R, Ferrero OL, Palacios R, Wyen C, Domingo P, Monin MB, Camino X, Montero M, Killer A, Malin JJ, de Los Santos I, Esser S, Morano LE, López-Cruz I, Valencia J, Vogelmann R, Mauss S, Rivero A, Elamouri F, Hidalgo-Tenorio C, Cielniak I, van Bremen K, Pérez-Somarriba J, Sanz J, Rozplochowski B, Beer D, Baumgarten A, Haberl A, Galindo MJ, Fariñas MC, Raczynska A, Voit F, Qurishi N, Noe S, Reus S, Khaykin P, Schneeweiss SM, Wandeler G, Boyd A, de Miguel M, Bellón JM, Parczewski M, Rockstroh JK.

    Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.

    CLINICAL INFECTIOUS DISEASES . 83(4): 572-576.

    [doi:10.1093/cid/ciag341]

  • Troya J, Cabello-Clotet N, Bernardino JI, Galindo MJ, Martínez RM, Martín J, Alemán MR, Torralba M, Fanjul F, Fariñas MC, Rodríguez A, Crusells MJ, Calzado S, Pérez-Serrano J, Hidalgo-Tenorio C, Morano LE, Vinuesa D, Bernal-Morell E, Poquet-Catalá I, Pernas-Pardavila H, Tiraboschi J, Corps D, Vivancos MJ, Buzón-Martín L.

    Immune Trajectories After Switch to Long-Acting Cabotegravir Plus Rilpivirine in the RELATIVITY Cohort.

    Open Forum Infectious Diseases . 13(10): .

    [doi:10.1093/ofid/ofag583]

  • Buzón L, Cabello-Clotet N, Montes ML, Galindo MJ, María Martínez R, Santacreu M, Remedios-Alemán M, Torralba M, Fanjul F, Gutiérrez-Cuadra M, Rodríguez A, Crusells MJ, Navarro M, Aguilera-García M, Hidalgo-Tenorio C, Morano LE, Vinuesa D, Bernal-Morell E, de Andrés C, Pernas H, Tiraboschi J, Bendala A, Vivancos MJ, Díez C, Soria G, Pérez D, Cairó M, Romero A, Cabo R, Soler J, Sepúlveda MA, Bravo J, Escrich C, Ferreira E, Valentín B, Muelas M, Lucas-Dato A, Gómez A, Cerezales A, Losa JE, Sanz J, Masía M, Corte-García JJ, Antolí A, Gainzarain JC, Estébanez M, Barragán P, Clavero M, Ferrero Ó, Troya J.

    Long-term Effectiveness, Treatment Persistence, and Timing of Virological Failure With Long-Acting Cabotegravir Plus Rilpivirine in Real-World HIV Care: RELATIVITY Cohort.

    Open Forum Infectious Diseases . 13(10): .

    [doi:10.1093/ofid/ofag622]

  • Ayala-Suárez R, De La Torre Tarazona E, Bermejo M, Bargalló ME, Maleno MJ, Coiras M, Leal L, García F, Plana M, García-Pérez J, Alcamí J, Díez-Fuertes F.

    sncRNA signatures underlying HIV-1 restriction in elite controllers.

    Frontiers in Cellular and Infection Microbiology . 16: 1926123-1926123.

    [doi:10.3389/fcimb.2026.1926123]

  • Huits R, Mileno MD, Norman FF.

    Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

    CURRENT OPINION IN INFECTIOUS DISEASES . 39(5): 415-421.

    [doi:10.1097/QCO.0000000000001212]

  • Wikman-Jorgensen PE, Iniesta C, Ruiz-Algueró M, Estrada V, Pulido F, Perez-Molina JA, Llenas-García J.

    Cost-effectiveness of lenacapavir versus tenofovir disoproxil fumarate plus emtricitabine for pre-exposure prophylaxis to prevent HIV-1 transmission in gay, bisexual, and other men who have sex with men in Spain.

    Lancet Regional Health-Europe . 69: 101807-101807.

    [doi:10.1016/j.lanepe.2026.101807]

  • Norman FF, McGuinness SL, Chen LH.

    Dengue and chikungunya vaccines past, present and future: implications for travelers.

    CURRENT OPINION IN INFECTIOUS DISEASES . 39(5): 404-414.

    [doi:10.1097/QCO.0000000000001211]

  • Mayoral-Alvarez J, Fernandez-Ibanez R, Sánchez-Conde M, Hermida JM, Vivancos MJ, Ron R, Martínez-Sanz J, Serrano-Villar S, Perez-Elias MJ, Moreno S.

    Younger age as a key predictor of follow-up abandonment among PrEP users: A retrospective cohort study in Madrid.

    HIV MEDICINE . 27(10): 1642-1649.

    [doi:10.1111/hiv.70287]

  • Hidalgo-Tenorio C, García-Aguilera M, Santos IL, Ruiz-Sancho A, Rivero A, López-Lirola A, Omar M, Romero A, Bernal E, Martinez O, López T, Sorni P, García-Ocaña P, Moreno S, Sanjoaquín I, Blanco JR, Garcia C.

    CABO-CHANCE study: A real-life world study of cabotegravir plus rilpivirine long-acting intramuscular in ART-experienced people with HIV.

    International Journal of Antimicrobial Agents . 67(10): 107909-107909.

    [doi:10.1016/j.ijantimicag.2026.107909]

  • Bogoch II, Barkati S, Díaz-Menéndez M, Epelboin L, Leung DT, Morris SK, Norman FF, Rolfe RJ, Vaughan SD, O'Laughlin K, Libman M, Goswami R.

    Hantavirus infection in returned travellers: data from the GeoSentinel Network.

    JOURNAL OF TRAVEL MEDICINE . 33(6): .

    [doi:10.1093/jtm/taag062]

  • Pericàs JM, Cañas MA, Goenaga MA, Nevado C, Kestler M, De La Villa S, Muñoz P, Blanes R, Tasias M, Escudero-Sánchez R, Moreno-García J, Alonso-Socas MM, Rodríguez-Esteban Á, Calderón-Parra J, Diego-Yagüe I, Boix-Palop L, García-Álvarez L, Gasch O, Careta O, Paredes R, Luzko IS, Garcia-De-La-Mària C, Hernández-Meneses M, Cuervo G, Moreno A, Arias CA, Miró JM.

    A Multicenter Prospective Protocol to Explore the Relationship Between Enterococcus faecalis Bloodstream Infections and Colorectal Neoplasms (EnteroColonus-GAMES Project).

    Microorganisms . 14(10): .

    [doi:10.3390/microorganisms14102178]

  • Belhassen-García M, de la Calle-Prieto F, Del Moral Sánchez JM, Alonso-Sardón M, Ayuso-Garcia B, Blanco JR, Bustos Morell C, Campany-Herrero D, Carranza C, Ercilla Liceaga M, Garcia López-Hortelano M, García-Vázquez E, Garrido B, Hernandez Cabrera M, Ibero C, Illaro Uranga A, Jimenez Núñez C, Kortajarena Urkola X, Lapeña J, Llenas-García J, López-Vizcaíno A, Losada-Galvan I, Merino P, Moreno Á, Mulet AM, Navarro M, Pardo Lledías J, Perez-Molina JA, Periañez Parraga L, Picazo Sanchís G, Pozo Rosado L, Praena-Segovia J, Salas-Coronas J, Salvador F, Urda-Romacho J, Romay-Barja M.

    Territorial inequities in access to essential medicines for neglected tropical diseases in a decentralised European health system: a nationwide assessment in Spain.

    Infectious Diseases of Poverty . 15(1): .

    [doi:10.1186/s40249-026-01489-8]